Covidien to Present at J.P. Morgan Healthcare Conference

Updated

Covidien to Present at J.P. Morgan Healthcare Conference

MANSFIELD, Mass.--(BUSINESS WIRE)-- Covidien (NYS: COV) , a leading global provider of healthcare products, will present at the 31st Annual J.P. Morgan Healthcare Conference in San Francisco, California, on January 7, 2013. Joe Almeida, Chairman, President and Chief Executive Officer, will discuss the Company in a presentation scheduled to begin at 8:30AM PT (11:30AM ET).

A live audio webcast of the presentation can be accessed at Covidien's Investor Relations website: http://investor.covidien.com. An archived edition of the presentation will be available following the live webcast.


About Covidien

Covidien is a leading global healthcare products company that creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence. Covidien manufactures, distributes and services a diverse range of industry-leading product lines in three segments: Medical Devices, Pharmaceuticals and Medical Supplies. With 2012 revenue of $11.9 billion, Covidien has 43,000 employees worldwide in 70 countries, and its products are sold in over 140 countries. Please visit www.covidien.com to learn more about our business.

anImage
anImage



Covidien
Eric Kraus, 508-261-8305
Senior Vice President
Corporate Communications
eric.kraus@covidien.com
or
Coleman Lannum, CFA, 508-452-4343
Vice President
Investor Relations
cole.lannum@covidien.com
or
Bruce Farmer, 508-452-4372
Vice President
Public Relations
bruce.farmer@covidien.com
or
Todd Carpenter, 508-452-4363
Director
Investor Relations
todd.carpenter@covidien.com

KEYWORDS: United States North America Massachusetts

INDUSTRY KEYWORDS:

The article Covidien to Present at J.P. Morgan Healthcare Conference originally appeared on Fool.com.

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2012 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Advertisement